Consolidated Statement Of Cash Flows

Sumitomo Pharma Co., Ltd. - Filing #7303560

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
As at
2023-09-30
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
1,000,000 JPY
JPY
JPY
-32,229,000,000 JPY
JPY
JPY
-32,228,000,000 JPY
JPY
JPY
-32,229,000,000 JPY
JPY
JPY
JPY
-67,741,000,000 JPY
5,000,000 JPY
-67,736,000,000 JPY
JPY
JPY
-67,741,000,000 JPY
JPY
JPY
JPY
Depreciation and amortization
13,689,000,000 JPY
18,659,000,000 JPY
Income tax expense
-178,000,000 JPY
11,609,000,000 JPY
Decrease (increase) in inventories
7,558,000,000 JPY
-4,006,000,000 JPY
Increase (decrease) in provisions
4,466,000,000 JPY
-38,512,000,000 JPY
Other
-7,967,000,000 JPY
-67,716,000,000 JPY
Subtotal
-6,568,000,000 JPY
-150,056,000,000 JPY
Interest received
441,000,000 JPY
1,402,000,000 JPY
Dividends received
447,000,000 JPY
497,000,000 JPY
Interest paid
-2,425,000,000 JPY
-1,737,000,000 JPY
Income taxes paid
-886,000,000 JPY
-24,603,000,000 JPY
Net cash provided by (used in) operating activities
4,552,000,000 JPY
-174,497,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,066,000,000 JPY
-4,256,000,000 JPY
Proceeds from sale of property, plant and equipment
1,024,000,000 JPY
384,000,000 JPY
Purchase of intangible assets
-4,195,000,000 JPY
-4,183,000,000 JPY
Net cash provided by (used in) investing activities
97,451,000,000 JPY
32,675,000,000 JPY
Cash flows from financing activities
Net increase (decrease) in short-term borrowings
-28,412,000,000 JPY
49,000,000,000 JPY
Dividends paid
-1,000,000 JPY
-2,785,000,000 JPY
Other
318,000,000 JPY
331,000,000 JPY
Net cash provided by (used in) financing activities
-29,436,000,000 JPY
44,797,000,000 JPY
Net increase (decrease) in cash and cash equivalents
72,567,000,000 JPY
-97,025,000,000 JPY
Cash and cash equivalents
99,082,000,000 JPY
29,047,000,000 JPY
60,397,000,000 JPY
143,478,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-1,404,000,000 JPY
12,809,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.